Xiao T, Cai Y, Chen B
Viruses. 2021; 13(5).
PMID: 33922579
PMC: 8146413.
DOI: 10.3390/v13050735.
Chen B
Trends Microbiol. 2019; 27(10):878-891.
PMID: 31262533
PMC: 6744290.
DOI: 10.1016/j.tim.2019.06.002.
Ivan B, Sun Z, Subbaraman H, Friedrich N, Trkola A
PLoS Biol. 2019; 17(1):e3000114.
PMID: 30650070
PMC: 6351000.
DOI: 10.1371/journal.pbio.3000114.
Falkenhagen A, Joshi S
Mol Ther Nucleic Acids. 2018; 13:347-364.
PMID: 30340139
PMC: 6197789.
DOI: 10.1016/j.omtn.2018.09.003.
Scinto H, Gupta S, Thorat S, Mukhtar M, Griffiths A, Delgado J
J Virol. 2018; 92(14).
PMID: 29743361
PMC: 6026739.
DOI: 10.1128/JVI.02222-17.
Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
Zheng Y, Han G, Abagyan R, Wu B, Stevens R, Cherezov V
Immunity. 2017; 46(6):1005-1017.e5.
PMID: 28636951
PMC: 5572563.
DOI: 10.1016/j.immuni.2017.05.002.
HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.
Levast B, Barblu L, Coutu M, Prevost J, Brassard N, Peres A
PLoS One. 2017; 12(3):e0174550.
PMID: 28346521
PMC: 5367833.
DOI: 10.1371/journal.pone.0174550.
A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.
Connell B, Chang S, Prakash E, Yousfi R, Mohan V, Posch W
PLoS One. 2016; 11(10):e0165386.
PMID: 27788205
PMC: 5082894.
DOI: 10.1371/journal.pone.0165386.
Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.
Kuzmina A, Vaknin K, Gdalevsky G, Vyazmensky M, Marks R, Taube R
PLoS One. 2015; 10(12):e0144043.
PMID: 26629902
PMC: 4667905.
DOI: 10.1371/journal.pone.0144043.
Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.
Pan R, Chen Y, Vaine M, Hu G, Wang S, Lu S
Emerg Microbes Infect. 2015; 4(7):e44.
PMID: 26251831
PMC: 4522616.
DOI: 10.1038/emi.2015.44.
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.
Kufareva I, Salanga C, Handel T
Immunol Cell Biol. 2015; 93(4):372-83.
PMID: 25708536
PMC: 4406842.
DOI: 10.1038/icb.2015.15.
Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms.
Cenci A, DAvenio G, Tavoschi L, Chiappi M, Becattini S, Narino M
PLoS One. 2014; 9(4):e95183.
PMID: 24788065
PMC: 4005737.
DOI: 10.1371/journal.pone.0095183.
Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domains.
Cavrois M, Neidleman J, Santiago M, Derdeyn C, Hunter E, Greene W
J Virol. 2013; 88(4):2083-94.
PMID: 24335304
PMC: 3911571.
DOI: 10.1128/JVI.02308-13.
Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality.
Hamoudi M, Simon-Loriere E, Gasser R, Negroni M
Retrovirology. 2013; 10:114.
PMID: 24156625
PMC: 3826872.
DOI: 10.1186/1742-4690-10-114.
Structure and dynamics of the gp120 V3 loop that confers noncompetitive resistance in R5 HIV-1(JR-FL) to maraviroc.
Yuan Y, Yokoyama M, Maeda Y, Terasawa H, Harada S, Sato H
PLoS One. 2013; 8(6):e65115.
PMID: 23840315
PMC: 3695986.
DOI: 10.1371/journal.pone.0065115.
Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.
De Feo C, Weiss C
Viruses. 2013; 4(12):3859-911.
PMID: 23342377
PMC: 3528295.
DOI: 10.3390/v4123859.
Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop.
Ong Y, Kirby K, Hachiya A, Chiang L, Marchand B, Yoshimura K
Cell Mol Biol (Noisy-le-grand). 2013; 58(1):71-9.
PMID: 23273194
PMC: 3612353.
Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C viruses.
Crous S, Shrestha R, Travers S
BMC Infect Dis. 2012; 12:203.
PMID: 22938574
PMC: 3482586.
DOI: 10.1186/1471-2334-12-203.
HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins.
Li Y, ODell S, Wilson R, Wu X, Schmidt S, Hogerkorp C
J Virol. 2012; 86(20):11231-41.
PMID: 22875963
PMC: 3457177.
DOI: 10.1128/JVI.01543-12.
Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheet.
Schiavone M, Fiume G, Caivano A, de Laurentiis A, Falcone C, Fasanella Masci F
Int J Mol Sci. 2012; 13(5):5674-5699.
PMID: 22754323
PMC: 3382813.
DOI: 10.3390/ijms13055674.